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Abstract
Background: Cardiac tumors are uncommon in the pediatric population. When present, cardiac manifestations
stem from the tumor causing inflow or outflow obstruction. While common in adults, cardiac myxomas presenting
with generalized systemic illness or peripheral emboli especially with no cardiac or neurological symptoms are rare
in children.
Case presentation: We report a case of a previously healthy adolescent girl who presented with a 6-month history
of constitutional symptoms and a purpuric rash with no cardiac or neurologic symptoms, found to have a cardiac
myxoma.
Conclusions: A vasculopathic rash in the setting of atrial myxomas has been shown be a precursor to significant
morbidity and mortality. Due to the rarity of this entity, the time elapsed from onset of non-cardiac symptoms until
diagnosis of a myxoma is usually prolonged with interval development of irreversible neurological sequelae and
death reported in the literature. Therefore, we highlight the importance of including cardiac myxomas and
paraneoplastic vasculitis early in the differential diagnosis for patients presenting with a purpuric rash and systemic
symptoms.
Keywords: Myxoma, Purpuric rash, Systemic symptoms, Neurological sequelae, Paraneoplastic vasculitis, Embolic
phenomena
Background
Cardiac tumors are rare in the pediatric population,
found in less than 0.5% of children evaluated for car-
diac disease [1]. Atrial myxomas are the most common
cardiac tumor in adults, most commonly presenting
with cardiac symptoms. Embolic phenomena, and con-
stitutional or systemic signs [2, 3] follow cardiac symp-
toms in frequency. In pediatrics, myxomas comprise
less than 15% of cardiac tumors [1, 4–6] and presenta-
tion with non-cardiac, constitutional symptoms is rare.
Thus, we report a case of an adolescent girl who pre-
sented with a rash, fever, purpura, and elevated inflam-
matory markers found to have to a cardiac myxoma.
Our case establishes a unique precedent of a diagnosis
of cardiac myxoma manifesting with systemic symp-
toms and a vasculopathic rash, but no neurological em-
bolic phenomena.
Case presentation
A 13-year-old previously healthy girl presented to the
emergency department (ED) for evaluation of fever, bi-
lateral foot pain, and rash. Her symptoms began
6 months prior to presentation, occurring 1–2 times per
month, lasting for 2–3 days, and improving with ibupro-
fen. A few weeks prior to ED presentation, she noted on-
set of fatigue, pain in her hip and calf, which she
attributed to her competitive soccer playing, and acute
abdominal pain with diarrhea and emesis.
Patient denied fever, headaches, visual changes, oral ul-
cers, muscle pain, or changes in bowel and bladder
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functions. She had no other medication use or recent
travel. Her family history was negative for autoimmune
diseases.
Her vital signs upon presentation showed a
temperature of 39.2 degrees Celsius, heart rate of 90
beats per minute, respiratory rate of 20 breaths per
minute, blood pressure of 114/62 mmHg, and 97%
oxygen saturation on room air. She had a blanchable,
retiform, violaceous patches with few areas of true
purpura on her bilateral lower extremities and duski-
ness of her right second toe (Fig. 1). The remainder
of her physical exam was unremarkable: a regular
heart rate and rhythm with normal S1, S2 and no
murmurs, rubs, or gallops; 2+ symmetric peripheral
pulses; and joints with full range of motion without
effusion or warmth. Her neurological exam was nor-
mal with no focal deficits. Her inflammatory markers
were elevated (Table 1) and she was admitted for fur-
ther evaluation.
Initial diagnostic considerations were vasculitis, in-
cluding cutaneous polyarteritis nodosa, leukocytoclastic
vasculitis (associated with lupus erythematosus, infec-
tion or idiopathic), versus a vasculopathy due to anti-
phospholipid antibody syndrome, cryoglobulinemia,
coagulopathy or septic emboli (Table 2).
Skin biopsy of a non-palpable purpuric area on the
dorsum of her left foot demonstrated subtle ischemia,
vascular congestion, purpura, and focal eccrine gland
necrosis without evidence of vasculitis, which was concern-
ing for a vasculopathic process. Direct immunofluorescence
of the skin biopsy was negative. Extensive systemic
work-up was unremarkable and included: hepatitis panel,
cryoglobulins, lupus anticoagulant panel, cardiolipins,
beta-2-microglobulin, beta-2-glycopreotin, complements 3
and 4, antistreptolysin O (ASO) titers, anti-DNAse B, and
aldolase. Abdominal and renal Doppler ultrasounds were
also unremarkable.
During her hospital course, she developed recurrent
fevers that were treated with acetaminophen at typical
doses. In addition, she received a 1-time dose IV meth-
ylprednisolone 1 mg/kg after her battery of laboratory
tests and skin biopsy.
An echocardiogram was performed to screen for
intra-cardiac thrombus and assess for coronary abnor-
malities due to concerns for vasculitis. The echocardio-
gram revealed a 2.5 by 3-cm (cm) mass in the left
Fig. 1 Skin findings at presentation, including retiform patches, purpura and duskiness of right 2nd toe. Left foot dorsum with biopsy sutures
in place
Table 1 Inflammatory markers at initial presentation
Laboratory Value Reference Range
Creatinine Kinase 1076 < 300 U/L
LDH 1216 100-250 U/L
CRP 48.8 < 10.0 mg/L
ESR 16 < 20.0 mm/hr
AST/ALT 164/89 10-50 U/L; 10-40 U/L
GGT 14 5–35 U/L
IL-6 < 0.5 ng/Mla
Abbreviations: LDH lactate dehydrogenase, CRP C-reactive protein, ESR
erythrocyte sedimentation rate, AST aspartate transaminase, ALT alanine
transaminase, GGT gamma-glutamyl transferase, Il Interleukin
aLevel drawn 6 days after initial presentation and 4 days after a IV dose
of methylprednisolone
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atrium (LA), Fig. 2. Cardiac magnetic resonance was
performed for tissue characterization of the LA mass
[7] and showed a 2.7 × 2.3 cm lobulated and mobile
mass within the left atrium adherent to the septum
(Fig. 2), consistent with a left atrial myxoma.
The patient’s rash and constitutional symptoms
were attributed to the myxoma. Purpura and pain in
the right toe was felt to be secondary to either
micro-embolic phenomenon or vasospasm. The deci-
sion was made to proceed with surgical excision of
the cardiac mass. She was observed off anticoagula-
tion given the lack of any concerning neurologic
symptoms until surgery, which followed shortly
thereafter.
The patient underwent an uncomplicated surgical re-
section and the diagnosis of cardiac myxoma was con-
firmed histologically (Fig. 3). She had an uncomplicated
post-operative course with resolution of fevers and
systemic symptoms in the immediate post-operative
period. At 3-week follow-up she continued to be
afebrile with near complete resolution of her skin find-
ings (Fig. 4). She had no concerning symptoms at her
8-month follow up.
Discussion and conclusions
Cardiac tumors are rare in children with an incidence of
0.17–0.2% [8, 9]. The most common pediatric cardiac
tumors are rhabdomyomas [1, 4, 5, 10–12], 10% of
which are familial and associated with Carney complex
[6]. Cardiac myxomas have been diagnosed more fre-
quently with the advent of echocardiography [3] and are
most commonly located in the left atrium [5]. In chil-
dren, the mean age of diagnosis is 9–10 years [5, 13].
Delayed or undiagnosed cardiac myxomas can result in
severe or fatal complications due to embolization of
these friable tumors or cardiac obstruction [14, 15].
As illustrated by our patient’s recurrent fevers, fa-
tigue, skin findings and elevated inflammatory markers,
cardiac myxomas can present with variable clinical
symptoms that mimic other conditions (Table 2). Extra-
cardiac manifestations are often caused by embolic phe-
nomena and inflammation due to the intrinsic
secretion of cytokines. In a series of 112 cases in adults,
34% of patients presented with systemic or constitu-
tional symptoms and 16% presented with embolic man-
ifestations [3]. However, review of the literature reveals
only 6 reported cases of pediatric cardiac myxomas pre-
senting with systemic symptoms without cardiac mani-
festations [15–21] and no cases of distal emboli without
concurrent neurologic symptoms from cerebral emboli.
Our case’s unique presentation with both systemic
symptoms and vasculopathy (possibly due to emboli or
vasospasm) highlights the importance of early recogni-
tion of the many features of these tumors to prevent to
morbidity and mortality related to emboli.
A case series of children with cardiac myxomas
causing cerebral emboli emphasizes the need for ex-
pedient diagnosis of cardiac myxomas; 6 out of 9 of
these children had residual neurologic deficits and 1
died post-operatively [22]. Several of these children
had distal extremity skin lesions noted before their
neurologic events, demonstrating that earlier diagnosis
Table 2 Differential diagnosis
Rheumatologic/
hematologic
Neoplastic Infectious Cardiac
Polyarteritis nodosa Paraneoplastic
vasculitis
Septic emboli Cardiac
myxoma
Leukocytoclastic
vasculitis, inflammatory
Leukocytoclastic
vasculitis
Coagulopathy (i.e.,
antiphospholipid
syndrome,
cryoglobulinemia,
other inherited
disorder)
Henoch-Schonlein purpura
Fig. 2 Echocardiographic image in the apical four chamber view shows a pedunculated mass attached to the atrial septum, red arrow. Cardiac
magnetic resonance imaging stud, the axial four-chamber view shows the left atrial mass. Tissue characterization with T1 and T2 weighted
images, first pass gadolinium perfusion and delayed enhancement sequences was highly suggestive of a myxoma
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is possible with an elevated index of suspicion. Inter-
estingly, none of these cases had associated systemic
symptoms or significantly elevated inflammatory
markers as our patient did, indicating that we cannot
attribute all of her symptoms to embolic phenomena
and consider inflammation intrinsic to the myxoma
as well (Table 3).
Cardiac myxoma is known to secrete pro-inflammatory
cytokine interleukin 6 (IL-6) and serum IL-6 plasma level
is correlated with constitutional symptoms [23]. Serum
IL-6 level was normal in our case but this was exam-
ined after IV methylprednisolone was initiated. A previ-
ous report demonstrated that 11 out of 12 patients
(92%) with cardiac myxoma related vasculitis experi-
enced improvement of symptoms with steroid adminis-
tration, thus her normal IL-6 level likely reflected prior
steroid therapy [2] .
Paraneoplastic vasculitis is an under recognized diag-
nosis, occurring in 5.2% of vasculitis cases [24]. Given
the rarity of the concurrent conditions, diagnosis of ma-
lignancy is often delayed and the mean interval before
diagnosis of malignancy is reported to be 11.9 months.
A diagnosis of vasculitis requires rheumatological and
infectious investigation, but search for malignancy is
mandatory when clinical course becomes chronic and
refractory to conventional therapy. While there have
been several case series of cardiac myxomas mimicking
vasculitis in adults and 2 reports in children nd 2 reports
in children [2], our patient did not have any evidence of
vasculitis on biopsy, making it unlikely that systemic in-
flammation was the etiology of our patient’s distal skin
findings.
In our case, systemic vasculitis and vasculopathy were the
initial diagnostic considerations given our patient’s systemic
symptoms and distal purpura. An echocardiogram quickly
Fig. 3 3.5 X 3.5 X 2.5 lobular, gelatinous, myxomatous mass
following resection from left atrium in the operating room.
Microscopic examination substantiated the diagnosis of a myxoma
Fig. 4 Resolution of purpura with minimal residual erythema at the right second toe 3 weeks after resection
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Fig. 5 Timeline
Table 3 Review of non-cardiac presentations of cardiac myxomas in the pediatric literature
Reference Number of patients; age (years)/
Gender
Systemic
symptoms
Embolic signs Elevated IL-
6
Xu [25] 1;13/F None Headache NA
Goldberg [15] 1; 3/M None Right hemiparesis, red spots on foot; died NA
Omeroglu [26] 2; 4/F, 6/F None Stroke NA
Al-Mateen [22] 2; 11/F, 10/M None Acute hemiplegia, transient ischemic attack, red spots NA
Hovels [16] 1; 6/F Fever, arthralgia None yes
Park [17] 1; 5/M Vasculitis None NA
Shiraishi [18] 1 Fever none NA
Patel [20] 1;17 /M Fatigue; rash none NA
Kaminsky [21] 1;14/M Arthropathy None NA
Saji [19] 1 NA NA NA
Domanski [27] 1; 8/M None Stroke NA
Tipton [28] 1; 17/M None Right hemiparesis, lethargy NA
Bobo [29] 1; 15/F None Right hemiparesis, headache NA
Tonz [30] 1; 8/M None Right hemiparesis, seizures, aphasia, red spots, retinal artery
occlusion
NA
Hung [31] 1; 10/F None Right hemiparesis, retinal artery occlusion NA
Bayir [32] 1; 14/F None Right hemiparesis, aphasia, slurred speech, cool right leg NA
Landers [33] 1; 8/F None Right hemiparesis, expressive aphasia, pulmonary embolus NA
Macias 1:13/F Fever, fatigue Purpura/distal emboli No
Embolic signs include stoke, purpura, retinal artery occlusion. Systemic symptoms include fever, arthralgia, and fatigue. NA not applicable as not evaluated or not
mentioned in work up
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raised high suspicion for cardiac myxoma, supported by tis-
sue characterization by MRI. This allowed for expedient
tumor resection and improvement of symptoms (Fig. 5).
This case emphasizes the importance of considering a car-
diac myxoma in a patient with both systemic inflammation
and vasculopathic phenomena.
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